Virus vector
CA 2365026 A1 · Owner: Juridical Foundation, Japanese Foundation For Cancer Research · Inventors: Hamada, Hirofumi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
There have been required a virus vector useful in treating and diagnosing tumors such as malignant melanoma having resistance against the conventional therapy and being troublesome in prognosis as well as diagnostic and therapeutic methods for tumors by using such a virus vector. A virus vector constructed by fusing a protein constituting a virus with a ligand binding specifically to melanocyte-stimulating hormone (MSH) receptor and diagnostics and remedies for tumors with the use of this virus vector.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 24, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 24, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 24, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.